Evidence map›Paper›PMID 40277171›Full record

ReviewCurrent opinion in ophthalmology2025

Corneal neurotization for the treatment of neurotrophic keratopathy.

Sasha Hubschman, Mark I Rosenblatt, Maria S Cortina

Abstract readReview
In one paragraph

Review in Current opinion in ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sasha HubschmanIllinois Eye & Ear Infirmary, Department of Ophthalmology and Visual Sciences.
Mark I RosenblattIllinois Eye & Ear Infirmary, Department of Ophthalmology and Visual Sciences.
Maria S CortinaIllinois Eye & Ear Infirmary, Department of Ophthalmology and Visual Sciences.

Funding

Translational Core for Therapeutic and Diagnostic DevelopmentP30EY001792 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SHUKLA, DEEPAK · 1985 to 2025
$14.8M
Cell-derived therapies for corneal nerve repair: Structural and functional mechanismsR01EY035681 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ALI R DJALILIAN, Mark I Rosenblatt · 2024 to 2026
$2.1M
NEI NIH HHS P30 EY001792NEI NIH HHS R01 EY035681
6 · The paper itself

Abstract

purpose of reviewCorneal neurotization, a surgical technique that restores corneal sensation by transferring a healthy sensory nerve to the neurotrophic cornea, has emerged as a treatment of moderate to severe neurotrophic keratopathy. This review provides an overview of the indications, surgical techniques, and outcomes of corneal neurotization. RECENT

findingsCorneal neurotization can be performed via direct nerve transfer or indirect nerve grafting, with comparable long-term outcomes. Advances such as minimally invasive and endoscopic techniques, nerve allografts, and alternative donor nerves have expanded its accessibility. Studies show significant improvements in corneal sensation, epithelial integrity, and ocular surface health, with younger patients achieving faster and more complete recovery. The procedure has demonstrated efficacy across diverse neurotrophic keratopathy etiologies and is increasingly considered earlier in disease progression. SUMMARY: Corneal neurotization offers a promising, long-term solution for neurotrophic keratopathy by addressing the root cause of corneal anesthesia.

Indexed as

CorneaCorneal DiseasesNerve TransferOphthalmic NerveHumanscorneal neurotizationcorneal sensationnerve transferneurotrophic keratopathyophthalmic surgery

Identifiers

PMID40277171
PMCPMC12144539

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.